Protein Kinase C Protects Preconditioned Rabbit Hearts by Increasing Sensitivity of Adenosine A2b-Dependent Signaling During Early Reperfusion

作者: Atsushi Kuno , Stuart D. Critz , Lin Cui , Victoriya Solodushko , Xi-Ming Yang

DOI: 10.1016/J.YJMCC.2007.05.016

关键词:

摘要: Although protein kinase C (PKC) plays a key role in ischemic preconditioning (IPC), the actual mechanism of that protection is unknown. We recently found from IPC requires activation adenosine receptors during early reperfusion. We, therefore, hypothesized PKC might act to increase heart's sensitivity adenosine. limited infarct size isolated rabbit hearts subjected 30-min regional ischemia/2-h reperfusion and IPC's was blocked by inhibitor chelerythrine given revealing involvement at Similarly infused period increased phosphorylation protective kinases Akt ERK1/2 observed after IPC. Infusing phorbol 12-myristate 13-acetate (PMA), activator, mimicked protection. As expected, triggered PMA chelerythrine, but surprisingly it also MRS1754, an A2b receptor-selective antagonist, suggesting somehow facilitating signaling receptors. NECA [5′-(N-ethylcarboxamido) adenosine], potent not selective receptor agonist, dose-dependent manner. Pretreating with or brief ischemia had no effect on per se markedly lowered threshold for induce their phosphorylation. BAY 60-6583, highly caused Akt. MRS1754 prevented induced 60-6583. 60-6583 when These results suggest cardiac protective, because very low affinity endogenous unable trigger signaling. propose event occurs increases so can activate A2b-dependent

参考文章(34)
Luiz Belardinelli, Igor Feoktistov, Maria B. Grant, Italo Biaggioni, Sergio Caballero, Margaret I. Davis, Proliferation, Migration, and ERK Activation in Human Retinal Endothelial Cells through A2B Adenosine Receptor Stimulation Investigative Ophthalmology & Visual Science. ,vol. 42, pp. 2068- 2073 ,(2001)
Maria L. Trincavelli, Matteo Marroni, Daniela Tuscano, Stefania Ceruti, Alessia Mazzola, Nico Mitro, Maria P. Abbracchio, Claudia Martini, Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells Journal of Neurochemistry. ,vol. 91, pp. 1180- 1190 ,(2004) , 10.1111/J.1471-4159.2004.02793.X
Kenneth A. Jacobson, Xiao-Duo Ji, Gary L. Stiles, Chemical modification and irreversible inhibition of striatal A2a adenosine receptors. Molecular Pharmacology. ,vol. 42, pp. 123- 133 ,(1992)
Masafumi Kitakaze, Hiroharu Funaya, Tetsuo Minamino, Koichi Node, Hiroshi Sato, Yasunori Ueda, Yuji Okuyama, Tsunehiko Kuzuya, Masatsugu Hori, Ken-ichi Yoshida, Role of Protein Kinase C-α in Activation of Ecto-5′-nucleotidase in the Preconditioned Canine Myocardium☆ Biochemical and Biophysical Research Communications. ,vol. 239, pp. 171- 175 ,(1997) , 10.1006/BBRC.1997.7445
Xi-Ming Yang, Thomas Krieg, Lin Cui, James M Downey, Michael V Cohen, NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. Journal of Molecular and Cellular Cardiology. ,vol. 36, pp. 411- 421 ,(2004) , 10.1016/J.YJMCC.2003.12.008
Z XU, S PARK, R MUELLER, R BAGNELL, C PATTERSON, P BOYSEN, Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes. Cardiovascular Research. ,vol. 65, pp. 803- 812 ,(2005) , 10.1016/J.CARDIORES.2004.12.004
Tobias Eckle, Thomas Krahn, Almut Grenz, David Köhler, Michel Mittelbronn, Catherine Ledent, Marlene A. Jacobson, Hartmut Osswald, Linda F. Thompson, Klaus Unertl, Holger K. Eltzschig, Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A2B Adenosine Receptors Circulation. ,vol. 115, pp. 1581- 1590 ,(2007) , 10.1161/CIRCULATIONAHA.106.669697
H KIN, A ZATTA, M LOFYE, B AMERSON, M HALKOS, F KERENDI, Z ZHAO, R GUYTON, J HEADRICK, J VINTENJOHANSEN, Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine. Cardiovascular Research. ,vol. 67, pp. 124- 133 ,(2005) , 10.1016/J.CARDIORES.2005.02.015
Wolfgang Schlack, Markus Schäfer, Anselm Uebing, Stefan Schäfer, Ullrich Borchard, Volker Thämer, Adenosine A2-receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart. Journal of Cardiovascular Pharmacology. ,vol. 22, pp. 89- 96 ,(1993) , 10.1097/00005344-199307000-00015